ZNF124 and non-small cell lung carcinoma: Furthermore, circ_ZNF124 could still be amplified when treated RNA with RNase A before reverse transcription, while GAPDH could not be detected after RNase A treatment, indicating that circ_ZNF124 was stably exist in NSCLC cells (Fig. 1b).